While current ADA guidelines recommend aiming for > 70% TIR [33], a recent survey of 1026 patients with T1DM revealed that fewer than 20% of respondents perceived their current insulin therapy to be “very successful” in achieving the target TIR [49]. This evidence concerns the gene INS and type 1 diabetes mellitus.